Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 14/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8442525 | 0.89 | TBXA2R (0.52) | TBXAS1TBXA2R | |
| SCHEMBL8440583 | 0.81 | ALDH1A1 (0.56) | TBXA2R | |
| SCHEMBL8437957 | 0.81 | MEN1 (0.54) | TBXA2R | |
| SCHEMBL8441478 | 0.81 | ALDH1A1 (0.48) | TBXAS1TBXA2R | |
| SCHEMBL8442976 | 0.81 | ALDH1A1 (0.48) | TBXA2R | |
| SCHEMBL8440900 | 0.81 | ALDH1A1 (0.56) | TBXA2R | |
| SCHEMBL8437796 | 0.81 | ALDH1A1 (0.56) | SLC1A3SLC1A2SLC1A1TBXA2R | |
| SCHEMBL8520794 | 0.80 | TBXAS1 (0.50) | TBXAS1SLC1A3SLC1A2SLC1A1TBXA2R | |
| SCHEMBL8438766 | 0.79 | LMNA (0.53) | SLC1A3SLC1A2SLC1A1TBXA2R | |
| SCHEMBL8443153 | 0.79 | MEP1B (0.47) | TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5955505-A | TREATING NERVE DEGENERATIVE DISORDERS | NIPPON SUISAN KAISHA, LTD. (JP) | 1999-09-21 | — | — | US | disclosed |